Latest filing published 08 Apr 2026 for Alignment Healthcare, Inc., €200k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James M. Head: trading record in brief
James M. Head (finance chief) discloses dealings in 2 companies, chiefly Claritev Corp and Alignment Healthcare, Inc. In total, 7 filings cover trades dated from 29 November 2021 to 7 April 2026.
Market trades split into 1 purchase (€1.2M) and 1 sale (€200k). Purchases outweigh sales by €953k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants. 2026 to date brings no purchases and 1 sale.
On 8 April 2026 came the latest disclosure, an open-market sale for €200k in Alignment Healthcare, Inc. The latest purchase dates back some time: it was published 1,805 days ago, on 1 December 2021. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James M. Head
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,100 shares@ US$21.08100.0% of flowCommon StockSEC:0001628280-26-024291:0
- 103,002 shares0Common StockSEC:0001628280-26-018883:0
- 81,593 shares0Common StockSEC:0001628280-25-030008:0
- 226,997 shares@ US$1.1116.8% of flowClass A common stockSEC:0001793229-24-000028:0
- 2,222,222 shares0Class A common stockSEC:0001793229-23-000024:0
- 300,000 shares@ US$4.3483.2% of flowClass A common stockSEC:0001793229-21-000127:0Canonical exit: 27 Feb 2022 (T+90)
6 of 6 declarations
